The mesolimbic dopamine system originating in the ventral tegmental area (VTA) is involved in the development of depression, and firing patterns of VTA dopaminergic neurons are key determinants in this process. Here, we describe a crucial role for the M-type K v 7.4 channels in modulating excitability of VTA dopaminergic neurons and in the development of depressive behaviour in mice.
Introduction
Current treatments available for major depression are unsatisfactory due to their many side effects and low efficacy, leaving more than one-third of depressed individuals resistant to drug treatments (Wong and Licinio, 2001 ). In addition, antidepressants usually take several weeks to months to produce a therapeutic response. Thus, new strategies are needed to understand the pathophysiology of major depression and to develop new therapeutic treatments. Growing evidence has implicated the mesolimbic dopaminergic system originating in the ventral tegmental area (VTA) in the pathogenesis and treatment of depression (Dunlop and Nemeroff, 2007; Gershon et al., 2007; Krishnan et al., 2007) . The dopaminergic neurons of the VTA fire either tonically or in 'phasic' bursts, and these firing patterns were shown to encode different types of behaviour (Schultz, 2007) . The phasic burst firing of VTA dopaminergic neurons is sufficient to drive behavioural conditioning and elicit dopaminergic transients with magnitudes not achieved by longer, lowerfrequency spiking (Tsai et al., 2009 ). More importantly, it has been recently demonstrated that the phasic burst firing pattern of VTA dopaminergic neurons directly controls depression-like behaviour in rodent models of depression (Chaudhury et al., 2013; Tye et al., 2013) .
A key to understanding the molecular and cellular mechanisms underlying depression lies in deciphering the firing patterns of dopaminergic neurons in the VTA and identification of the main molecular players controlling such patterns (Grace et al., 2007) . Ionotropic NMDA receptors and Ca 2+ -activated K + channels (Creed et al., 2016) , HCN (Neuhoff et al., 2002; Cao et al., 2010) and K ir 3/GIRK channels (Munoz and Slesinger, 2004; Padgett et al., 2012) have all been suggested to play important roles in controlling either the intrinsic dopaminergic neuronal activity or the abusive drug-induced modulation of such activity. However, despite significant progress, a complete understanding of the firing patterns within the VTA circuitry and what controls these patterns is currently lacking. One emerging concept for treating depression is focused on modulation of the K + channels of VTA dopaminergic neurons (Overstreet and Wegener, 2013; Borsotto et al., 2015) . This concept is based on several experimental findings suggesting that K + channels controlling excitability of VTA dopaminergic neurons may be targeted to reduce the neuronal firing and the susceptibility of mice to social depression stress (Krishnan et al., 2007; Friedman et al., 2014; Friedman et al., 2016) . Several other studies have implicated K + channels in depression (even though some of these observations are not directly compatible); thus, genetic deletion of TREK1 K + channels
produces an intrinsic antidepressant-like phenotype, which is not affected by further treatment with SSRI antidepressants (Heurteaux et al., 2006) , while selective blockade of TREK1 channels with spadin or its analogues exerts a rapid antidepressant effect (Mazella et al., 2010; Veyssiere et al., 2015) . One family of K + channels, which is increasingly recognized for their role in controlling neuronal firing, is the K v 7/ KCNQ family. K v 7/KCNQ channels (K v 7.1-5) are voltagedependent potassium channels with five members, four of which (K v 7.2-5) are abundantly expressed in the CNS (Wang et al., 1998; Jentsch, 2000; Gamper and Shapiro, 2015) . Opening of K v 7 channels leads to neuronal hyperpolarization, membrane potential stabilization and decreased excitability. This makes these K + channels particularly interesting as targets in neurological disorders linked to hyperexcitability, including epilepsy, anxiety, pain, migraine and addiction to psychostimulants (Brown and Passmore, 2009 ). Interestingly, K v 7 channels are expressed in dopaminergic neurons (Hansen et al., 2006; Koyama and Appel, 2006) and have been suggested to modulate the excitability of dopaminergic neurons (Hansen et al., 2008; Drion et al., 2010) and dopaminergic transmission (Hansen et al., 2008) . On the transcriptional level, K v 7.4 channels were found to be a major KCNQ gene expressed in VTA dopaminergic neurons (Hansen et al., 2006) , although the functional expression and potential role of K v 7 channels in depression have not been elucidated. In this study, we provide strong evidence that K v 7.4 channels are a dominant subtype of K v 7 channels in the VTA and potent modulators of the excitability of VTA dopaminergic neurons. Because the expression of K v 7.4 channels in the CNS is much more restricted than the expression of other K v 7 channels, targeting this channel may offer a new approach to the treatment of depression, and such a strategy could be less prone to on-target side effects than current treatments.
Methods

Animals
All animal care and experimental procedures were conducted in accordance with the guidelines and with the approval of the Animal Care and Use Committee at Hebei Medical University. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Animals were housed in conditions of controlled temperature, humidity and lighting (12:12 h light-dark cycle) and given free access to food (provided by Experimental Animal Center of Hebei Province) and tap water ad libitum. Animals were allowed to adapt to their housing environment for at least 7 days prior to experimentation and to the experimental room for 1 day before experiments. K v 7.4 knockout mice (K v 7.4 À/À transfection. Human K v 7.2, rat K v 7.3 and human K v 7.4 (GenBank accession numbers: AF110020, AF091247, AF105202, respectively) were kindly provided by Diomedes E. Logothetis (Virginia Commonwealth University, Richmond, Virginia, USA) and were subcloned into pcDNA3.
VTA brain slice preparation
Brain slices containing VTA/substantia nigra (SN) were prepared as reported (Krishnan et al., 2007) . Mice were killed by pentobarbital sodium (200 mg·kg À1 , i.p), and brains were cut in a coronal plane and sectioned into slices (250μm) containing VTA/SN using a vibratome (VT1200S; Leica, Germany). The VTA was located stereotaxically, as described (Franklin and Paxinos, 2001) , as the region dorsal to the medial mammillary nucleus or the interpeduncular nucleus, medial to the SN and ventral to the red nucleus (Shabat-Simon et al., 2008) . The coronal slices (250 μm) were prepared in ice-cold oxygenated (95% O 2 /5% CO 2 ) cutting solution (in mM: KCl 2.5, NaH 2 PO 4 1.25, NaHCO 3 25, CaCl 2 0.5, MgCl 2 7, D-glucose 10 and sucrose 220; osmolarity, 295-305 mOsm) and incubated for 30 min at 36°C in oxygenated artificial CSF (aCSF) (in mM: NaCl 124, KCl 3, NaH 2 PO 4 1.24, MgCl 2 2, CaCl 2 2, D-glucose 10 and NaHCO 3 26; osmolarity, 280-300 mOsm). Four coronal slices (250 μm) containing the VTA/SN were obtained from each mouse. The slices were allowed to recover at room temperature (23-25°C) in oxygenated aCSF for at least 1 h prior to recording. Recordings were made at room temperature in a recording chamber continuously perfused with oxygenated aCSF (2 mL·min À1 ).
The human brainstem from a 45-year-old male who died of sudden cardiac death without neuropsychiatric, neurological or neurodegenerative disease was obtained from the Department of Forensic pathology of Hebei Medical University. The use of human tissue samples was approved by the Ethical Committee for Human Tissue Samples of Hebei Medical University.
Identificationof VTA dopaminergic neurons
Dopaminergic neurons were distinguished from nondopaminergic neurons either by the presence of tyrosine hydoxylase (TH), using single-cell PCR, or based on the functional characteristics of dopaminergic neurons as follows: (i) a sag hyperpolarization potential during injection of a hyperpolarizing current pulse (Supporting Information Figure S1A , B); (ii) a typical triphasic action potential with a negative deflection, an action potential width from the start to the minimum of >1.1 ms and an action potential duration (from start to recovery at resting membrane rest) > 2.5 ms (Supporting Information Figure S1C , D); (iii) firing rate less than 5 Hz (in loose patch or single-unit recordings where spontaneous firing was recorded; see below); and (iv) inhibition of the firing activity by dopamine (Ungless et al., 2004; Cao et al., 2010) .
Electrophysiology
K v 7 channel current recordings in CHO cells expressing these channels were made using the perforated patch configuration of the patch-clamp technique (amphotericin B, 250 μg·mL À1 , Sigma, USA) at room temperature using a HEKA EPC10 patch-clamp amplifier and Patch Master software (HEKA Electronics, Germany). Currents were acquired at 10 kHz and filtered at 2.5 kHz. Patch electrodes were pulled with a micropipette puller (Sutter Instruments, USA) and polished to 2-4 MΩ resistance. The intracellular solution contained the following (in mM): KCl 150, MgCl 2 5, HEPES 10, pH adjusted to 7.4 with KOH. Series resistance (generally below 10 MΩ) was compensated by 60-80%. The extracellular solution contained (in mM) the following: NaCl 160, KCl 2.5, MgCl 2 1, CaCl 2 2, glucose 10, HEPES 20; pH adjusted to 7.4 with NaOH. Cells were held at a holding potential of À60 mV, and 1 s test pulses to À10 mV were applied every 6 s.
For whole-cell current-clamp and voltage-clamp recordings in the VTA slices, an Axopatch 1D amplifier coupled with a Digidata 1440A AD converter (Molecular Devices, USA) was used, and the data were analysed using Clampex 10.3 (Molecular Device, USA) and OriginPro 8.5 software (Origin Lab Corporation, USA). For K v 7 channel/M current recordings, neurons were held at À10 mV and 1 s square pulses to À50 mV were delivered repeatedly at 20 s intervals. The M current was measured as the instantaneous deactivating tail current at the beginning of a voltage step to À50 mV. Whole-cell patch-clamp recordings were made with glass electrodes (4-6 MΩ) using an internal solution containing (in mM): K-methylsulfate 115, KCl 20, MgCl 2 1, HEPES 10, EGTA 0.1, MgATP 2 and Na 2 GTP 0.3, pH adjusted to 7.4 with KOH. The extracellular solution was the aCSF. A cell-attached 'loose-patch' (100-300 MΩ) (Burlet et al., 2002) recordings were also used to record spontaneous firing of dopaminergic neurons. In this case, the pipette solution contained aCSF.
Single-unit recordings were used to record the spontaneous firing of VTA dopaminergic neurons in vivo based on a previously reported method (Mameli-Engvall et al., 2006) . Briefly, mice were anaesthetized with 4% chloral hydrate (400 mg·kg À1 , i.p.); the coordinates for the VTA were 2.92-3.16 mm from the anterior fontanel, 0.50-0.70 mm lateral from the midline and 4.20-5.00 mm ventral from the cortical surface. Dopaminergic neurons were identified by their characteristic action potentials [typical triphasic action potentials with a negative deflection: the action potential width from the start to the minimum trough of ≥1.1 ms, a characteristic long duration (>2 ms) and a slow firing rate (<10 Hz)] (Cao et al., 2010) ( Figure 3F ). The presence of burst firing (as opposed to tonic firing) was identified by the following criteria: (i) the start of a burst was registered when two consecutive spikes fired within 80 ms; (ii) the end of the burst was registered when the interspike interval (ISI) exceeded 160 ms (Cao et al., 2010) ; and (iii) a neuron was considered as burst-firing if it fired at least one burst within 3 min. Electrical signals were amplified and filtered (10-4 K Hz) by the Axoclamp 900A preamplifier and recorder by the Digidata 1440A AD converter (Molecular Devices, USA); the data were analysed by Clampfit 10.3 (Molecular Devices, USA). The effect of 0.9% saline (vehicle), fasudil (20 mg·kg À1 )
or retigabine (10 mg·kg À1 ) on the firing activity of VTA dopaminergic neurons recorded using single-unit recordings was assessed 10 min after i.p. injection or 5 min after direct VTA local pressure (5-15 ψ) injection (see Figure 6 legend for detail). 
Chronic social defeat stress
The social defeat model of depression in mice was established based on the protocols reported previously (Krishnan et al., 2007) . Briefly, the C57BL/6 mice were subjected to attack by a CD1 mouse for 10 min a day for 10 days. CD1 retired breeders were selected before the test and the fiercest CD1 mice were excluded in the following experiment. In addition, the intensity of attack stimuli was minimized to produce stable depressive behaviour. To minimize harm and avoid physical injury, plastic dividers were set when C57BL/6 J mice displayed submissive behaviour, including immobility, crouching, trembling, fleeing and upright posture. On day 1 and day 11, the weight was recorded, and a sucrose preference test was performed as follows. Mice were individually accommodated in cages with two drinking water bottles for 24 h (food provided ad libitum). The animals were then deprived of water and food for 12 h. After this period, two drinking bottles were re-introduced with one containing 0.8% sucrose solution and the other filled with drinking water. Twelve hours later, the bottles were removed and weighed. Sucrose preference was calculated as a percentage [(weight of sucrose solution consumed / total weight of liquid consumed from two bottles) × 100%]. On day 13, the social interaction test was carried out. The C57BL/6 mice were placed in an interaction test box and allowed to move freely for 2.5 min in the absence or presence of an unfamiliar caged CD1 mouse. The time the test C57BL/6 mice spent in the interaction zone and in the corner zone (see Supporting Information Figure S2A , B) was analysed (Supporting Information Figure S2C ). Subgroups of susceptible (SUS) and unsusceptible (UNSUS) mice were identified. The animals were qualified as SUS to depression-like behaviour (SUS) if they spent significantly less time in the interaction zone while a CD1 mouse was present than while a CD1 mouse was not present. Animals that did not respond to the presence of a CD1 mouse by reduced interaction time were qualified as UNSUS mice. Sucrose preference was an additional test used to determine depression susceptibility (see below). Animals were divided into groups randomly. Experimenters were blinded to the drug treatment while performing the tests.
Cannula implantation for direct injection of drugs into the VTA Mice were anaesthetized by i.p. injection of 8% chloral hydrate (400 mg·kg À1 , i.p) and placed into a stereotaxic apparatus. Mice were bilaterally implanted with a stainless 26-gauge cannula fitted with obturators (Plastics One) targeting directly above the VTA with the following coordinates: anteroposterior, 3.08 mm; lateral, 0.50 mm; and dorsoventral, 4.20 mm. The cannulae were secured with dental cement; and the mice were then singly housed and allowed to recover for 3 days. After the surgery, the mice were housed at 28°C for 8 h to maintain their body temperature. All instruments were autoclaved, and the skin of the animals was sterilized with alcohol and iodine to prevent infection after surgery. The animals were placed in a cage with clean sawdust bedding and provided free access to fresh water and food (provided by the Experimental Animal Center of Hebei Province).
Western blotting
Mice were killed by pentobarbital sodium (200 mg·kg À1 , i.p) and perfused transcardially with 0.01 m ice-cold PBS. Brains were rapidly removed, and VTA punches (2 mm diameter, 2 mm thick) from these mice were sonicated in 1% SDS lysis buffer containing protease inhibitor and centrifuged at 4°C for 30 min at 17 220 g. Protein samples (40 mg) were separated by 10% SDS-PAGE for 1.5 h and transferred to a nitrocellulose membrane for 2 h in 20% transfer buffer. Membranes were then blocked for 1 h at room temperature in TBST (TBS and 0.1% Tween-20) with 5% non-fat milk (Sigma, USA) and then were incubated overnight at 4°C with primary antibody against K v 7.4 channel protein (1:1000, Alomone Labs, USA) or β-tubulin (1:10 000, Abcam, UK) diluted in TBST. Membranes were washed with TBST for 3 × 10 min, incubated with goat anti-rabbit (1:5000, Rockland, USA) or goat anti-mouse (1:7500, Rockland, USA) secondary antibodies for 1 h at room temperature and washed with TBST for 2 × 10 min followed by another 10 min wash with TBS. Membranes were imaged using an Odyssey infrared imaging system (LI-COR, USA); the integrated optical density of each band was measured using ImageJ software (National Institutes of Health, USA).
Immunofluorescence
For experiments shown in Figure 1D , mice were killed by pentobarbital sodium (200 mg·kg À1 , i.p.) and perfused transcardially with 0.01 m ice-cold PBS, followed by ice-cold PBS containing 4% paraformaldehyde (PFA). The brain was removed, fixed in 4% PFA at 4°C for 48 h and embedded in paraffin. Paraffin coronal VTA/SN slices (5 μm) were mounted on glass slides. Coronal VTA/SN slices located at 1.40 to 0.50 mm from λ. Slices were dewaxed in xylene and rehydrated in alcohol. Antigen retrieval was achieved by microwave heating (three times for 3 min) of the brain slices. Sections were blocked with 10% goat serum (Biological Industries, Israel) in PBS and incubated overnight with a mixture of mouse anti-TH (1:100, Merck Millipore, Germany, Cat# MAB318 Lot#, RRID: AB_2201528) and rabbit anti- For experiments shown in Figure 1A , the brain was fixed in 4% PFA at 4°C for 24 h and embedded in 30% sucrose for 24 h. Coronal VTA/SN slices (60 μm) were cut using a vibratome (VT1200S; Leica, Germany). Sections were blocked with 10% goat serum overnight with a mixture of two primary antibodies: mouse anti-TH (1:100, Merck Millipore, Germany) and rabbit anti-K v 7.2 (1:100, Santa Cruz, CA, Cat# sc-7793, RRID: AB_2296585), goat anti-K v 7.3 (1:100, Santa Cruz, CA, Cat# sc-7794 Lot#, RRID: AB_2131714), rabbit anti-K v 7.4 (1:100, AlomoneLabs, Israel) or rabbit anti-K v 7.5 (1:50, Santa Cruz, CA, Cat# sc-50416 Lot#, RRID: AB_2131834). Sections were then washed with PBS six times (5 min) and incubated in a mixture of two secondary antibodies: FITC-conjugated AffiniPure goat anti-mouse IgG ( Images were taken using a Leica TCS SP5 confocal microscope (Leica, Germany) equipped with laser lines for DAPI (800 nm, Ti-sapphire coherent pulsed), FITC (Argon 488), cy3 (HeNe 543) and cy5 (red diode 637 nm). Images were analysed with LAS-AF-Lite software (Leica).
Tissue blocks of the brainstem from human brain were fixed in 4% PFA at 4°C and embedded in paraffin. Slices were dewaxed and rehydrated. Antigen retrieval and incubation with antibodies were performed by the same protocol used for mouse samples.
Single-cell PCR
Neurons were aspirated into a patch pipette at the end of electrophysiological recordings. The electrode tip was then broken into a PCR tube containing 1 μL of oligo-dT (50 mM) and 1 μL of dNTP mixture (10 mM). The mixture was heated to 65°C for 5 min to denature the nucleic acids and then placed on ice for 1 min. Single-strand cDNA was synthesized from the cellular mRNA by mixing 2 μL of 5× PrimeScript II buffer (50 mM), 0.5 μL of RNase inhibitor (40 U·μL À1 ) and 1 μL of PrimeScript II RTase (200 U·μL À1 ) and then incubating the mixture at 50°C for 50 min. Synthesis of single-cell cDNA was performed using a C1000 Touch thermal cycler-CFX96 Real-time PCR system (California, USA). First-strand synthesis was executed at 95°C (5 min) followed by 35 cycles (95°C for 1 min, 56°C for 45 s, 72°C for 50 s) and a final 10 min elongation at 72°C by adding the specific 'outer' primer pairs to each PCR tube (final volume 25 μL). Then, 2 μL of the product of the first PCR was used in the second amplification round by using the specific 'inner' primer (final volume 50 μL). The second amplification round consisted of heating the samples to 95°C for 5 min followed by 30 cycles (95°C for 1 min, 54-62°C for 45 s, 72°C for 50 s) and 10 min elongation at 72°C. The products of the second round of PCR were analysed in 2.5% agarose gels and stained with ethidium bromide. A PrimeScriptTM II 1 st Strand cDNA Synthesis Kit and GoTaq Green Master Mix were obtained from Takara-Clontech (Kyoto, Japan) and Promega (Madison, USA) respectively.
The 'outer' primers (from 5 0 to 3 0 ) are as follows:
The 'inner' primers (from 5 0 to 3 0 ) are as follows:
qRT-PCR
Total RNA from the VTA of mice was extracted using a mirVana miRNA Isolation Kit (Invitrogen, USA) according to the manufacturer's recommendations. The RNA was reverse transcribed into cDNA using a PrimeScript ™ RT reagent kit with gDNA Eraser (TAKARA, RR047A, Japan). qRT-PCR of Kv7.4 and GAPDH was performed using an ABI PRISM 7300 Sequence Detection System (Applied Biosystems, USA) with a SYBR® Premix Ex Taq ™ II (TliRNaseH Plus) kit (TAKARA, RR820A, Japan). The relative amounts of transcripts were normalized to GAPDH; the relative RNA expression levels were calculated using the following equation: relative gene expression = 2 À(△Ct sample À △Ct control) . The following primers were used.
Data and statistical analysis
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . Sample size was determined through power analysis using preliminary data obtained in our laboratory with the following assumptions: 'α' of 0.05 (two-tailed) and power of 90%. 
Materials
Retigabine and Y-27632 were from Sigma-Aldrich (China). Fasudil was from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). XE991 dihydrochloride was from Alomone Labs (Jerusalem, Israel). RL-648_81 (Kumar et al., 2016) was synthesized by the Department of New Drugs Development, School of Pharmacy, Hebei Medical University. All solutions were prepared freshly on the test day.
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www. guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 (Alexander et al., 2015a,b,c) .
Results K v 7.4 channels are selectively expressed in VTA DA neurons
Among the K v 7/KCNQ isoforms, K v 7.4 is the predominant KCNQ gene transcript present in the midbrain VTA (Hansen et al., 2006) . We first performed detailed analysis of protein and mRNA expression of K v 7/KCNQ isoforms in the midbrain of mice, with a special interest in the expression of these K v 7 channels in dopaminergic neurons (identified by the expression of TH). In the immunofluorescence study ( Figure 1A , C), K v 7.2-K v 7.5 channels were differentially expressed in the dopaminergic neurons of the VTA and the SN of the mouse midbrain. Overall, among the four K v 7 isoforms, K v 7.4 was more selectively expressed in VTA than in the dopaminergic neurons of the SN. Thus, while 66% of TH-positive (dopaminergic) neurons in the VTA expressed K v 7.4 channels, only 27% of these neurons in the SN expressed this channel (P < 0.05; Fisher's exact test). Among the other K v 7 channels, only K v 7.5 exhibited a (non-significant) trend towards a higher incidence of expression in the VTA, compared to the SN ( Figure 1C ), yet the proportion of K v 7.5-positive neurons in the VTA was still significantly lower compared to the proportion of K v 7.4-positive neurons ( Figure 1C ). Interestingly, K v 7.2 channels were significantly more frequently expressed in SN neurons compared to VTA neurons ( Figure 1C ). K v 7.3 and K v 7.5 channels were expressed in much smaller proportions of VTA dopaminergic neurons ( Figure 1C) . Similarly, in a single-cell PCR study ( Figure 1B, C) , K v 7.4 channels were also more selectively expressed in VTA dopaminergic neurons, with a trend towards more K v 7.2 channels in SN dopaminergic neurons ( Figure 1C ). K v 7.4 channels were absent from the VTA dopaminergic neurons of the K v 7.4 knockout mice (K v 7.4 À/À ) ; Figure 1D ).
Expression of K v 7.4 channels was also found in human VTA dopaminergic neurons ( Figure 1E ). Taken together, the results presented in Figure 1 demonstrate that, while several K v 7 channels are expressed in VTA dopaminergic neurons, the K v 7.4 channels are predominant.
Fasudil selectively activates K v 7.4 currents in VTA dopaminergic neurons
We next aimed to selectively modulate K v 7.4 channels to regulate the excitability of VTA dopaminergic neurons. Our first goal was to identify a selective modulator of K v 7.4 channels. In a separate investigation of the effects of Rho-associated protein kinase (ROCK; Uehata et al., 1997) inhibitor fasudil in the cardiovascular system, we discovered that fasudil is also a selective opener of K v 7.4 channels . Here, in CHO cells that exogenously express K v 7.4 channels, fasudil enhanced K v 7.4 channel currents, in a concentrationdependent manner, but did not affect currents carried by K v 7.2 channels (Supporting Information Figure 2A1 -A3).
Retigabine, a prototypic, non-selective, opener of K v 7 channels (Tatulian et al., 2001) , enhanced both K v 7.4 and K v 7.2 channel currents, which were inhibited by the K v 7 channel blocker XE991 (Supporting Information Figure 2A1 , A2). Importantly, fasudil did not activate heterologously expressed K v 7.2/K v 7.3 multimeric channels (Supporting Information Figure S3 ), which are the major carriers of the M-type current in the CNS (Wang et al., 1998) . Fasudil did not affect K v 7.1 and K v 7.3 channels but did activate K v 7.4/ K v 7.5 multimers . Thus, we concluded that fasudil is a selective activator of K v 7.4-containing homo-and heteromeric K v 7 channels. We then tested the effect of fasudil on K + currents in VTA neurons. We recorded K v 7/M-like currents from VTA/SN slices of adult mice (6-8 weeks). The currents were recorded using the protocol shown in the right panel of Figure 2B1 as the characteristic slow deactivating tail current at À50 mV, which is defined as the 'M current' and is mostly conducted by K v 7 channels (Koyama and Appel, 2006) . Accordingly, almost 50% of the deactivating current was inhibited by XE911 (3 μM; Figure 2B1 ). In these experiments, we used well-established characteristics to select dopaminergic neurons (Supporting Information Figure S1 ; see Methods for details). As reported and consistent with our results shown in Figure 1 , the majority (~70%) of VTA neurons are dopaminergic neurons, with a small population of GABAergic neurons and glutamatergic neurons (Nair-Roberts et al. Figure 2C ) could arise from other K v 7 channels (Figure 1 A-C). We also tested the effects of fasudil on K v 7/M-like currents of SN dopaminergic neurons. In contrast to its effects in VTA dopaminergic neurons, fasudil did not induce significant activation of K v 7/M currents in SN neurons (from 94.1 ± 0.7 to 94.4 ± 0.2 pA after treatment with 100 μM fasudil; n = 22, P > 0.05, paired t-test).
K v 7.4 channel activity controls the excitability of VTA dopaminergic neurons
Next, we tested the influence of K v 7.4 channels on the excitability of VTA dopaminergic neurons. Excitability was recorded using a loose cell-attached patch method (Burlet et al., 2002; Williams and Wozny, 2011 ) from brain slices of WT and K v 7.4 À/À mice. We recorded from VTA neurons located primarily in the lateral part of the VTA, as projections from this population of VTA dopaminergic neurons are more likely to be involved in depression-like behaviour (Barbara and Han, 2016) . The placement of recording electrodes and the positions of recorded neurons are shown in the schematic of Figure 3A2 (top). We recorded the spontaneous firing of VTA neurons with action potential wave form characteristics of dopaminergic neurons (Supporting Information Figure S1 , Methods) ( Figure 3A1 , right panel). Fasudil (10 μM) significantly reduced the average firing frequency of VTA neurons ( Figure 3A1, D) . Post-recording single-cell PCR analysis confirmed that the inhibitory effect of fasudil resulted from activation of K v 7.4 channels, as fasudil only inhibited firing in VTA dopaminergic neurons that expressed these channels but did not inhibit firing in K v 7.4-negative neurons ( Figure 3A2 ). The dopaminergic phenotype of these neurons was additionally confirmed by TH expression ( Figure 3A2 ). Fasudil did not affect the firing frequency in VTA dopaminergic neurons from K v 7.4 À/À mice ( Figure 3B, D) . Consistent with the limited expression of K v 7.4 channels in the SN, the firing of dopaminergic neurons in the SN was not significantly affected by fasudil ( Figure 3C, D) . On the other hand, the firing of both VTA and SN neurons was inhibited by the non-selective K v 7 channel opener, retigabine and by a selective K v 7.2 channel opener RL-648-81 (10 μM; Kumar et al., 2016) ( Figure 3A-D) . The effects of retigabine were still present in neurons from K v 7.4 À/À mice ( Figure 3B, D) . These data support our finding that K v 7.2 channels are present in both VTA and SN neurons (Figure 1 ). In further evidence supporting a role of K v 7.4 channels in controlling DA neuron excitability, we found that the absence of K v 7.4 channels (Kv7.4 À/À ) provides VTA dopaminergic neurons with a higher spontaneous firing frequency ( Figure 3E ). Furthermore, dopaminergic neurons in the SN of WT mice, which have limited expression of K v 7.4 channels, also had a higher firing frequency compared to VTA dopaminergic neurons from WT mice ( Figure 3E ). On the other hand, no difference in firing frequency between SN neurons from WT mice and K v 7.4 À/À mice was found ( Figure 3E ). We further tested the effects of K v 7 channel modulation on the excitability of VTA VTA dopaminergic neurons neurons using current-clamped, whole-cell recordings from VTA slices. In these experiments, the following parameters were recorded: (i) the resting membrane potential (Supporting Information Figure S4A ); (ii) the induced action potential firing frequency (Supporting Information Figure S4B , C); and (iii) the spontaneous firing rates (Supporting Information Figure S4D ). Comparison of these parameters between neurons fromWT and K v 7.4 À/À mice clearly indicated that K v 7.4 channels constitutively modulated the excitability of VTA dopaminergic neurons. Finally, the contribution of K v 7.4 channels to the regulation of excitability on VTA dopaminergic neurons was also assessed in an in vivo setting. The spontaneous firing of VTA dopaminergic neurons was recorded in vivo using an extracellular single-unit recording method ( Figure 3F ). In this recording paradigm, two patterns of firing ( Figure 3F , expanded traces) were often recorded from the same neurons, the tonic firing ( Figure 3F1 ) and burst firing ( Figure 3F2 ; see Methods for detail), and both total firing frequency and the burst firing properties were analysed (Krishnan et al., 2007) . In WT mice, fasudil (i.p.; 20 mg·kg À1 ) reduced the total firing frequency ( Figure 3G1 , G2) and the percentage of spikes in bursts ( Figure 3G3 ) and increased the ISI ( Figure 3G1 ). In marked contrast, in K v 7.4 À/À mice, neither the total firing frequency nor the percentage of spikes in bursts was affected by fasudil treatment ( Figure 3G2 , G3).
The role of K v 7.4 channels in the development of a depression-like phenotype in the social defeat model of depression
Increased activity of VTA dopaminergic neurons is directly related to depression-like behaviours in the social defeat model of depression (Cao et al., 2010; Chaudhury et al., 2013; Friedman et al., 2014.; Krishnan et al., 2007) . Because K v 7.4 channels play a significant role in controlling the excitability of VTA dopaminergic neurons, we investigated whether altered K v 7.4 channel activity could be a causal factor for the increased excitability of VTA dopaminergic neurons observed in the social defeat mice model. For this, we first established a model of social defeat ( Figure 4A , Supporting Information Figure S2 ; see Methods for detail). The depression-like state of mice was confirmed by a reduction in sucrose preference ( Figure 4B ) and reduced social interaction time when an 'aggressor' CD1 mouse was present ( Figure 4C ). Mice that exhibited reduction in both parameters were defined as 'SUS mice'. Mice with both parameters unaltered were identified as 'UNSUS mice' (Krishnan et al., 2007; Chaudhury et al., 2013) . Consistent with the previous reports, the firing activity of VTA dopaminergic neurons, recorded using the in vivo singleunit recording method, was higher in SUS mice than in control and UNSUS mice ( Figure 4D ). Importantly, burst firing also increased in SUS mice compared to control and UNSUS mice ( Figure 4E ) and this increase has been reported to be an important determinant of depression-like behaviour in mice (Krishnan et al., 2007; Chaudhury et al., 2013) .
We then recorded K v 7/M currents of VTA dopaminergic neurons from SUS and UNSUS mice. As shown in Figure 4F , K v 7/M currents were reduced in SUS mice compared with control and UNSUS mice (Figure 4) . To test if the reduced K v 7/M currents were due to down-regulated expression of K v 7.4 channels, we first measured K v 7.4 mRNA levels using The firing of VTA dopaminergic neurons was recorded using single-unit recording. Each point in the chart represents a result from a separate mouse. (I) K v 7.4 protein levels measured using Western blots. *P < 0.05, significantly different as indicated; one-way ANOVA; n is the number of cells and N is the number of animals. Figure 4G demonstrated that the mRNA levels of K v 7.4 were indeed lower in the VTA of SUS mice compared with control and UNSUS mice. We also performed a correlation analysis and found that the firing frequency of VTA dopaminergic neurons was strongly negatively correlated with the expression level of K v 7.4 mRNA (R 2 = 0.75), regardless of the SUS/UNSUS phenotype ( Figure 4H ). We also measured the levels of K v 7.4 protein in the VTA and found that the abundance of this protein in the VTA of SUS mice was similarly reduced, Supporting Information Figure S7 , compared with the levels in control and (to a lesser extent) UNSUS mice ( Figure 4I ), in good agreement with the RT-PCR data.
qPCR. The results shown in
Fasudil reduces the excitability of VTA dopaminergic neurons and reverses depression-like behaviour
The results thus far allowed us to hypothesize that fasudil, by activating K v 7.4 channels in VTA dopaminergic neurons, should be able to ameliorate the increased excitability of VTA dopaminergic neurons and the related depression-like behaviour in a social defeat mouse model of depression. We used several approaches to test this hypothesis. First, we used the cell-attached recordings of the firing of VTA dopaminergic neurons from control, SUS and UNSUS mice. Indeed, fasudil reduced the firing rate of VTA dopaminergic neurons in SUS mice and control mice to similar extent (by about 30%) ( Figure 5A1, A2) . These results are consistent with reduced (but not abolished) expression of K v 7.4 channels and reduced M current amplitudes in the VTA DA neurons of SUS mice.
In further experiments, using in vivo single-unit recordings, we found that the total firing activity of dopaminergic neurons in the VTA of WT mice was decreased and that ISI increased significantly following i.p. injection of fasudil (20 mg·kg À1 ) or retigabine (10 mg·kg À1 ) but not vehicle (0.9% saline, 0.15 mL; Figure 5B , C). Similarly, burst firing was also decreased after treatment with fasudil and retigabine ( Figure 5D , E). However, in K v 7.4 À/À mice, fasudil failed to affect the firing of VTA dopaminergic neurons whereas retigabine remained effective, albeit with a reduced efficacy ( Figure 5C ). Most importantly, the social defeat-induced avoidance behaviour of WT SUS mice was reversed by acute administration (i.p.) of fasudil and retigabine. Specifically, in vehicletreated SUS mice, introduction of the unfamiliar CD1 mouse into the interaction test box (Supporting Information Figure  S2B ; Methods) induced an avoidance response from the tested mice. Thus, the time that the tested mice spent in the interaction zone was reduced ( Figure 5F ), indicating depression-like behaviour induced by social defeat. However, when WT SUS mice were injected with either retigabine or fasudil, the time that the tested mice spent in the interaction zone in the presence of the 'aggressor' CD1 mouse was not significantly different from the control period (without the 'aggressor'). This indicates that K v 7 channel openers indeed abolished the avoidance reaction to the introduction of the unfamiliar CD1 mice, indicating a reversal of depression-like social interaction deficit. It should be noted that when a CD1 mouse was absent, the time spent in the interaction zone for SUS mice from vehicle, fasudil or retigabine treatment groups ( Figure 5F ) was not significantly different. In K v 7.4 À/À mice, however, fasudil failed to affect the behavioural response of SUS mice to the presence of the CD1 'aggressor' ( Figure 5G ). Retigabine however, was still effective ( Figure 5G ), but its effect was highly variable. Notably, under retigabine treatment, WT and K v 7.4 À/À mice became less active, that is, their mobility in the open field test was significantly reduced (Supporting Information Figure S5B, C) . This is consistent with the previously reported sedative effect of retigabine (Hayashi et al., 2014) . Fasudil, on the other hand, did not affect the general activity of the mice of either genotype (Supporting Information Figure S5B , C). These data suggest that retigabine, but not fasudil, exerts a central, sedative effect independent of K v 7.4 channels. To provide direct evidence that fasudil, when administered systemically through i.p. injection, reversed the fault in social interaction of the social defeat mice through action on VTA dopaminergic neurons, fasudil was also infused directly onto the VTA through a cannula implanted to deliver at the VTA ( Figure 6E , see Methods for details). Different concentrations of fasudil (and retigabine) were first tested to select a concentration of the drug to obtain an effect on the firing activity of dopaminergic neurons, comparable to that recorded after systemic administration. Ultimately, 200 μM was chosen to further test the effects of localized drug delivery on social interaction behaviour. At 200 μM, both fasudil and retigabine induced significant inhibition on VTA neuron firing activity ( Figure 6A-C ). Social interaction was tested at two time points after fasudil was administered, 5 and 40 min; a timematched (5 min) vehicle control was also tested ( Figure 6D ). At both time points, local VTA infusion of fasudil or retigabine abolished 'aggressor' avoidance and normalized the time a mouse spent in the interaction zone ( Figure 6F ) and in the corner zone ( Figure 6G ) in the presence of a CD1 'aggressor'. Thus, as observed with systemic administration, direct local injection of fasudil into the VTA also reversed the depression-like social interaction behaviour.
Discussion
Here, we demonstrate that (i) K v 7.4 channels are selectively expressed in VTA dopaminergic neurons and represents a major K v 7/M channel in these cells; (ii) K v 7.4 channels play a key role in the regulation of the excitability of VTA dopaminergic neurons; (iii) down-regulation of K v 7.4 channels contributes importantly to the increased excitability of the VTA dopaminergic neurons and, thus, may trigger the development of a depression-like state in mice; and finally, (iv) fasudil is a selective opener of K v 7.4 channels, and its targeted modulation of these channels significantly improves depression-like behaviour in the social defeat mouse model of depression. As the excitability of VTA dopaminergic neurons is critical in the development of depressive state (Chaudhury et al., 2013; Tye et al., 2013) Kv7.4 regulation of depression-like behaviours BJP 2008). This reduces the risk of on-target side effects of a selective K v 7.4 channel-based therapy, compared to broadspectrum M channel targeting with currently available drugs such as retigabine. Consistent with this hypothesis, in our behavioural experiments, fasudil did not produce a sedative effect, while retigabine was clearly sedative (Supporting Information Figure S5 ). The fact that fasudil is already a clinically approved drug used for the treatment of cerebral vascular spasm (Uehata et al., 1997) makes these findings even more relevant. Importantly, the anti-excitatory effects of fasudil in the VTA are likely to be independent of its Rho kinase inhibitor activity, as another unrelated Rho kinase inhibitor, Y-27632, did not affect the excitability of VTA dopaminergic neurons recorded either in vitro or in vivo (Supporting Information Figure S6 ). The argument that K + channel openers can be used to treat depression is based on the rationale that increased excitability of VTA dopaminergic neurons is linked to the development of depression, and thus, K + channel openers may help to reverse the over-excitable state of the VTA. The VTA activation theory is applicable to the social defeat depression model (Krishnan et al., 2007; Cao et al., 2010; Chaudhury et al., 2013; Friedman et al., 2014) . In this model of depression, it is believed that increased phasic firing of VTA dopaminergic neurons via increased release of BDNF in the nucleus accumbens (NAc) confers individual susceptibility to stressful stimulation (Krishnan et al., 2007; Chaudhury et al., 2013) . Elevated K + channel activity could counteract the increased VTA dopaminergic activity and alleviate depressive behaviour (Krishnan et al., 2007; Friedman et al., 2014; Friedman et al., 2016) . Thus, the VTA dopaminergic activation theory would involve the increased burst firing rates of VTA-NAc dopaminergic neurons as a crucial mediator of social stressinduced depressive behaviour (Walsh and Han, 2011) . Our results conform well to this theory: the targeted activation of K v 7.4 channels reduced the increased excitability of VTA dopaminergic neurons and at the same time improved the depression-like behaviour of socially defeated mice. Importantly, the selective opener of K v 7.4 channels produced much fewer side effects compared to the broad-spectrum K v 7 channel opener retigabine. The elevated neuronal excitability in VTA dopaminergic neurons from K v 7.4 À/À mice might suggest a phenotype of depression. However, this was not the case; no depressive behaviour was observed in K v 7.4 À/À mice and these mice developed depressive behaviour after being subjected to the stressful stimulation. This indicates that the elevated excitability of VTA neurons is essential, but not sufficient, for inducing the depression behaviour, and therefore, additional factors, such as corticotrophin release factor (Walsh and Han, 2011) , may be necessary. Thus, a stress context is a precondition for the involvement of VTA dopaminergic neurons in the development of depressive behaviour (Chaudhury et al., 2013) . The role of VTA dopaminergic neurons in the development of depression raises another question: could the reduced expression or activity of K + channels (including that of K v 7 channels induced, e.g. by stress) (Zhou et al., 2016) be a causative factor in the altered firing of VTA dopaminergic neurons and the depression-like behaviours related to such altered firing? The results found thus far suggest that this may be the case. Earlier studies showed that elevated expression/activity of K + channels (including K v 7.3/KCNQ3) could be responsible for the lack of susceptibility in a subpopulation of mice that do not develop depression-like behaviour in the social defeat paradigm (Krishnan et al., 2007; Friedman et al., 2014; Friedman et al., 2016) . In the current study, we found that the mRNA and protein expression of K v 7.4 channels were lower in SUS mice, compared with those in UNSUS mice. Thus, our study suggests that the down-regulation of K v 7.4 channel abundance is possibly one of the causative factors of changes in the excitability of VTA dopaminergic neurons, which determines depressive behaviours (Chaudhury et al., 2013; Tye et al., 2013) .
It has to be noted that our findings were obtained with the use of a single depression model. Different models of depression may involve different neuronal mechanisms, including the activity of VTA dopaminergic neurons (e.g. reduced activity of VTA dopaminergic neurons in the depression model of the unpredictable chronic mild stress, in mice; Chaudhury et al., 2013; Tye et al., 2013) . This may underlie the complexity of major depressive states demonstrated in patients and their heterogeneous responses to antidepressants. Therefore, further studies are necessary to test if the mechanisms discovered here contribute to development of depression in other animal models and in patients. Nevertheless, targeting a causal molecular mechanism of depression (such as a loss of functional activity of K v 7.4 channels), rather than fighting symptoms of the disease, might provide a better strategy for development of new antidepressants.
In summary, in this study, we provide strong evidence that K v 7.4 channels are a key modulator of the excitability of VTA dopaminergic neurons, which contributes to the development of depressive behaviour. Furthermore, selective targeting of K v 7.4 channels in VTA dopaminergic neurons with drugs such as fasudil, presents a potential new strategy for the treatment of major depressive disorders.
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